| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
35,571 |
27,441 |
$3.80M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,022 |
871 |
$1K |
| 90670 |
|
140 |
109 |
$215.33 |
| 90723 |
|
69 |
49 |
$79.15 |
| 90647 |
|
64 |
50 |
$26.23 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,327 |
10,955 |
$18.21 |
| 36415 |
Collection of venous blood by venipuncture |
2,709 |
2,425 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,666 |
1,458 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,213 |
8,398 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
109 |
109 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
957 |
779 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,156 |
1,779 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
589 |
477 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
2,440 |
2,107 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
149 |
141 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
591 |
505 |
$0.00 |
| 90834 |
Psychotherapy, 45 minutes with patient |
32 |
16 |
$0.00 |
| 87807 |
|
84 |
83 |
$0.00 |
| 87428 |
|
912 |
877 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
502 |
476 |
$0.00 |
| 90686 |
|
336 |
273 |
$0.00 |
| 90688 |
|
38 |
28 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
145 |
115 |
$0.00 |
| 87430 |
|
164 |
164 |
$0.00 |
| 3074F |
|
535 |
505 |
$0.00 |
| 87088 |
|
19 |
12 |
$0.00 |
| 90651 |
|
55 |
54 |
$0.00 |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
124 |
118 |
$0.00 |
| 3080F |
|
140 |
135 |
$0.00 |
| 81001 |
|
50 |
26 |
$0.00 |
| 90696 |
|
14 |
14 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
43 |
25 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
13 |
13 |
$0.00 |
| 81025 |
|
498 |
428 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
227 |
209 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
13 |
12 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,228 |
1,037 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
468 |
417 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,099 |
1,523 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
445 |
360 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
634 |
589 |
$0.00 |
| 99173 |
|
207 |
194 |
$0.00 |
| 81003 |
|
147 |
136 |
$0.00 |
| 99201 |
|
223 |
163 |
$0.00 |
| 90734 |
|
108 |
101 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
109 |
109 |
$0.00 |
| 80348 |
|
80 |
68 |
$0.00 |
| 80061 |
Lipid panel |
288 |
283 |
$0.00 |
| 90710 |
|
37 |
33 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
645 |
370 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
265 |
248 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
294 |
203 |
$0.00 |
| 3078F |
|
531 |
501 |
$0.00 |
| 3077F |
|
140 |
135 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
49 |
42 |
$0.00 |
| 90832 |
Psychotherapy, 30 minutes with patient |
148 |
67 |
$0.00 |
| 90715 |
|
52 |
44 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
17 |
16 |
$0.00 |
| 90633 |
|
29 |
27 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
13 |
13 |
$0.00 |